165 related articles for article (PubMed ID: 38429268)
1. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract][Full Text] [Related]
2. Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS.
Liuyu T; Yu K; Ye L; Zhang Z; Zhang M; Ren Y; Cai Z; Zhu Q; Lin D; Zhong B
Cell Res; 2019 Jan; 29(1):67-79. PubMed ID: 30410068
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1.
Ma X; Wan R; Wen Y; Liu T; Song Y; Zhu Y
Exp Cell Res; 2024 Jan; 434(1):113864. PubMed ID: 38040050
[TBL] [Abstract][Full Text] [Related]
4. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
[TBL] [Abstract][Full Text] [Related]
5. OTUD4 Is a Phospho-Activated K63 Deubiquitinase that Regulates MyD88-Dependent Signaling.
Zhao Y; Mudge MC; Soll JM; Rodrigues RB; Byrum AK; Schwarzkopf EA; Bradstreet TR; Gygi SP; Edelson BT; Mosammaparast N
Mol Cell; 2018 Feb; 69(3):505-516.e5. PubMed ID: 29395066
[TBL] [Abstract][Full Text] [Related]
6. OTUD4 alleviates hepatic ischemia-reperfusion injury by suppressing the K63-linked ubiquitination of TRAF6.
Liu H; Fan J; Zhang W; Chen Q; Zhang Y; Wu Z
Biochem Biophys Res Commun; 2020 Mar; 523(4):924-930. PubMed ID: 31964525
[TBL] [Abstract][Full Text] [Related]
7. OTUD4 enhances TGFβ signalling through regulation of the TGFβ receptor complex.
Jaynes PW; Iyengar PV; Lui SKL; Tan TZ; Vasilevski N; Wright SCE; Verdile G; Jeyasekharan AD; Eichhorn PJA
Sci Rep; 2020 Sep; 10(1):15725. PubMed ID: 32973272
[TBL] [Abstract][Full Text] [Related]
8. OTUD4: A Potential Prognosis Biomarker for Multiple Human Cancers.
Zhao X; Su X; Cao L; Xie T; Chen Q; Li J; Xu R; Jiang C
Cancer Manag Res; 2020; 12():1503-1512. PubMed ID: 32184655
[TBL] [Abstract][Full Text] [Related]
9. UBE2T promotes glioblastoma invasion and migration via stabilizing GRP78 and regulating EMT.
Huang P; Guo Y; Zhao Z; Ning W; Wang H; Gu C; Zhang M; Qu Y; Zhang H; Song Y
Aging (Albany NY); 2020 Jun; 12(11):10275-10289. PubMed ID: 32491994
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.
Wang J; Li B; Wang C; Luo Y; Zhao M; Chen P
J Cell Biochem; 2019 Dec; 120(12):19784-19795. PubMed ID: 31347720
[TBL] [Abstract][Full Text] [Related]
11. USP14 regulates cell cycle progression through deubiquitinating CDK1 in breast cancer.
Liu Y; Xu J; Wang Y; Gan M; Hu Q; Wang J; Han T
Acta Biochim Biophys Sin (Shanghai); 2022 Nov; 54(11):1610-1618. PubMed ID: 36604147
[TBL] [Abstract][Full Text] [Related]
12. CSE reduces OTUD4 triggering lung epithelial cell apoptosis via PAI-1 degradation.
Luo L; Li T; Zeng Z; Li H; He X; Chen Y
Cell Death Dis; 2023 Sep; 14(9):614. PubMed ID: 37726265
[TBL] [Abstract][Full Text] [Related]
13. Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent.
Chinyama HA; Wei L; Mokgautsi N; Lawal B; Wu ATH; Huang HS
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003585
[TBL] [Abstract][Full Text] [Related]
14. Identification of the potential oncogenes in glioblastoma based on bioinformatic analysis and elucidation of the underlying mechanisms.
Zhang Y; Xia Q; Lin J
Oncol Rep; 2018 Aug; 40(2):715-725. PubMed ID: 29901201
[TBL] [Abstract][Full Text] [Related]
15. MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells.
Dong Z; Zou J; Li J; Pang Y; Liu Y; Deng C; Chen F; Cui H
Cancer Med; 2019 Dec; 8(18):7793-7808. PubMed ID: 31691527
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells.
Li Z; Tian Y; Zong H; Wang X; Li D; Keranmu A; Xin S; Ye B; Bai R; Chen W; Yang G; Ye L; Wang S
Apoptosis; 2024 Mar; ():. PubMed ID: 38553613
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
[TBL] [Abstract][Full Text] [Related]
18. NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma.
Hu S; Yuan Y; Yan R; Xie H; Cai R; Xu J
Biochem Biophys Res Commun; 2024 May; 708():149798. PubMed ID: 38518721
[TBL] [Abstract][Full Text] [Related]
19. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
20. Atypical Ubiquitination and Parkinson's Disease.
Buneeva O; Medvedev A
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
